Corneal penetration behavior of beta-blocking agents III: In vitro-in vivo correlations
- PMID: 6139473
- DOI: 10.1002/jps.2600721110
Corneal penetration behavior of beta-blocking agents III: In vitro-in vivo correlations
Abstract
Aqueous humor levels were determined over time after the topical administration to rabbit eyes of 1% isotonic buffered (pH 7.3) solutions of three beta-blocking agents, acebutolol hydrochloride, timolol maleate, and bufuralol hydrochloride (arranged in order of increasing lipophilicity). Corneal permeability coefficients, determined from a previous in vitro study, were inversely related to the observed time to peak for the three drugs, as expected. Two of the drugs, bufuralol and timolol, did not give the expected rank order for Cmax and AUC, which could result from differences in distribution and/or elimination processes. Aqueous boundary layers were postulated for in vivo corneal permeability which suggested that bufuralol and timolol may have nearly identical effective permeability coefficients in vivo.
Similar articles
-
The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate.Invest Ophthalmol Vis Sci. 2013 Feb 7;54(2):1118-26. doi: 10.1167/iovs.12-10583. Invest Ophthalmol Vis Sci. 2013. PMID: 23307957 Free PMC article.
-
Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method.Exp Eye Res. 1998 Apr;66(4):487-94. doi: 10.1006/exer.1997.0448. Exp Eye Res. 1998. PMID: 9593641
-
Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.J Pharm Sci. 1983 Nov;72(11):1266-72. doi: 10.1002/jps.2600721108. J Pharm Sci. 1983. PMID: 6139471
-
Beta-adrenergic blockers: ocular penetration and binding to the uveal pigment.Jpn J Ophthalmol. 1982;26(3):248-63. Jpn J Ophthalmol. 1982. PMID: 6130180
-
Clinical pharmacokinetics of the eye. Proctor lecture.Invest Ophthalmol Vis Sci. 1981 Oct;21(4):504-41. Invest Ophthalmol Vis Sci. 1981. PMID: 6116682 Review.
Cited by
-
Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach.J Biomed Biotechnol. 2011;2011:483869. doi: 10.1155/2011/483869. Epub 2011 Feb 20. J Biomed Biotechnol. 2011. PMID: 21403901 Free PMC article.
-
Novel Role of Molecular Hydrogen: The End of Ophthalmic Diseases?Pharmaceuticals (Basel). 2023 Nov 7;16(11):1567. doi: 10.3390/ph16111567. Pharmaceuticals (Basel). 2023. PMID: 38004433 Free PMC article. Review.
-
Recent Advances in Studying In Vitro Drug Permeation Across Mucosal Membranes.Pharmaceutics. 2025 Feb 14;17(2):256. doi: 10.3390/pharmaceutics17020256. Pharmaceutics. 2025. PMID: 40006623 Free PMC article. Review.
-
Novel strategies for anterior segment ocular drug delivery.J Ocul Pharmacol Ther. 2013 Mar;29(2):106-23. doi: 10.1089/jop.2012.0200. Epub 2012 Dec 5. J Ocul Pharmacol Ther. 2013. PMID: 23215539 Free PMC article. Review.
-
Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: corneal permeability considerations.Cornea. 2013 Feb;32(2):179-84. doi: 10.1097/ICO.0b013e31825646de. Cornea. 2013. PMID: 22868628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources